Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Invitae to Underweight

JP Morgan Downgrades Invitae to Underweight

JP Morgan analyst Julia Qin downgrades Invitae (NYSE:NVTA) from Neutral to Underweight.

byBenzinga Newsdesk

August 10, 2022

1 minute read

JP Morgan analyst Julia Qin downgrades Invitae (NYSE:NVTA) from Neutral to Underweight.

News
Tech

Apple’s $3500 Vision Pro Could Reportedly Hit The Stores In The Last Week Of January

By Rounak Jain

January 3, 3:13 AM

Apple is now reportedly expected to launch its futuristic $3,500 Vision Pro headset in the last week of January.

AAPL

Analyst Ratings

Analyst Ratings for Alphabet

By Benzinga Insights

October 13, 4:00 PM

Within the last quarter, Alphabet (NASDAQ:GOOGL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

GOOGL

JP Morgan Upgrades Bunge to Overweight

By Benzinga Newsdesk

July 7, 11:59 AM

JP Morgan analyst Thomas Palmer upgrades Bunge (NYSE:BG) from Neutral to Overweight.

MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status

By Vuk Zdinjak

August 1, 8:05 AM

MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed the US FDA drug API manufacturer inspection at the company's Barrie, Ontario facility.

MEDIF

JP Morgan Downgrades Invitae to Underweight

Related Posts

Apple’s $3500 Vision Pro Could Reportedly Hit The Stores In The Last Week Of January

Analyst Ratings for Alphabet

JP Morgan Upgrades Bunge to Overweight

MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status